New U.S. Patent Allowance Granted to AXIM® Biotech for Use of All Cannabinoids in Its Controlled-Release Chewing Gum Products
16 nov. 2016 09h00 HE
|
AXIM Biotechnologies, Inc
NEW YORK, Nov. 16, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in hemp cannabinoid research and development, today announced that the United...
AXIM Biotech Begins Human Clinical Trials With Cannabigerol (CBG) for Psoriasis and Eczema in Patients
17 mai 2016 09h00 HE
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, May 17, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC:AXIM) is pleased to announce to shareholders and the public that the Company is launching human dermatological clinical...
Photo Release -- AXIM Biotechnologies Adds Health Industry Senior Marketing Executive Joe Grace to Advisory Board
26 août 2015 09h00 HE
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, Aug. 26, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC:AXIM) is proud to announce the latest appointment to its Board of Advisors: Mr. Joe Grace. A proven business and marketing...
AXIM Biotech Explains Cannabis Chewing Gum Clinical Trials for Pain and Spasticity With MS, Plans to Enter General Pain Market
20 août 2015 09h00 HE
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, Aug. 20, 2015 (GLOBE NEWSWIRE) -- News of clinical trials on a new pharmaceutical cannabis chewing gum treatment option for pain and spasticity in Multiple Sclerosis (MS) patients by AXIM...
AXIM Biotech Announces Launch of Clinical Trials on MedChew RX(TM) and Development of Pharmaceutical-Grade Cannabis Chewing Gum
11 août 2015 09h00 HE
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, Aug. 11, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC:AXIM) is a unique biotechnology corporation with a focus on global research, development and production of pharmaceutical,...
AXIM Biotech Presents Patented Cannabinoid Delivery Methods at My Compassion's Chicago Cannabis Conference
29 juil. 2015 09h00 HE
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, July 29, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC:AXIM) CEO George E. Anastassov, MD, DDS, MBA, proudly shared the Company's cannabinoid delivery methods – including...
Photo Release -- AXIM Biotechnologies, Inc. Supports Adopt-A-Soldier Platoon's Warfighter Independence Weekend
02 juil. 2015 12h08 HE
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, July 2, 2015 (GLOBE NEWSWIRE) -- When signing the Clay Hunt Suicide Prevention for American Veterans Act, President Obama called on Americans to, "Reach out and do more with and for our...
Photo Release -- AXIM Biotech CEO Addresses Cannabinoid Delivery Innovations at My Compassion's Cannabis Conference Chicago
23 juin 2015 10h33 HE
|
AXIM BIOTECHNOLOGIES, INC
CHICAGO, June 23, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC:AXIM), a unique hemp cannabis biotechnology innovator, is proud to announce that its Chief Executive Officer, George E....
Photo Release -- AXIM Biotech Garners Global Headlines After Announcing First-Ever Lines of Cannabigerol (CBG) Products
20 avr. 2015 15h12 HE
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, April 20, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC:AXIM), is pleased to announce that the company's innovative new hemp-based cannabigerol (CBG) product lines were covered in...
Photo Release -- Dr. Jacques F. Meis, World-Renowned Infectious Disease Specialist, Joins AXIM Biotechnologies, Inc.'s Advisory Board
18 mars 2015 12h31 HE
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, March 18, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies (OTC:AXIM), an industrial hemp biosciences industry leader, welcomes Dr. Jacques F. Meis, MD, PhD, world-renowned infectious disease...